Company: AZN
Filing Date: 2025-09-29
Form Type: 6-K
Source: 0001104659-25-094039
Chunk: 42

Company: ASTRAZENECA PLC
Filing Date: 2025-09-29
Form: 6-K
Chunk 42
---
 the online platform during the General Meeting should not submit voting instructions in advance.

Voting in advance will not prevent registered AstraZeneca ADS holders from participating in, and asking questions during, the General Meeting via the online platform.

Beneficial owners who hold AstraZeneca ADSs through a bank, broker or other nominee will receive information on providing voting instructions from such bank, broker or other nominee.

Holders of Swedish Listed Shares

Holders of Swedish Listed Shares should follow the instructions set out in the separate documents sent to them as the remainder of these Notes to the Notice of General Meeting do not apply to such persons.

Holders of Swedish Listed Shares will be able to ask questions of the Board via the online platform by following the instructions set out in the relevant documents.

Holders of Swedish Listed Shares should follow the voting instructions set out in the documents sent to them and are encouraged to vote in advance of the General Meeting, although arrangements will be in place to facilitate voting during the General Meeting. Where holders of Swedish Listed Shares have submitted voting instructions in advance, it will not be possible to vote, or change previously submitted voting instructions, during the General Meeting via the online platform. Therefore, any holder of Swedish Listed Shares wishing to vote via the online platform during the General Meeting should not submit voting instructions in advance.

Online platform

The Board strongly encourages all Shareholders (including holders of AstraZeneca Shares in a nominee account or brokerage account or through the CSN Facility) to participate in the General Meeting via the online platform, as the content and presentation will be optimised for that format. Shareholders, holders of AstraZeneca ADSs and holders of Swedish Listed Shares can attend from any physical location, by joining the online platform using a personal device. The online platform can be found at: https:// meetings.lumiconnect.com/100-392-363-424. Joining instructions are on pages 38 to 39 of this Notice and, for holders of Swedish Listed Shares and AstraZeneca ADSs, in the separate documents sent to them.

Shareholders’ right to ask questions

Any Shareholder participating in the General Meeting has the right to ask questions, and is welcomed to do so in advance of or during the General Meeting. The Company must answer any question relating to the business being dealt with at the meeting but no answer need be given if: (i) to do so would interfere unduly with the preparation for the meeting or involve the disclosure of confidential information; (ii) the answer has already